HMGA1 and lung carcinoma: Moreover, HSPA9 blocks the degradation of high mobility group A1 (HMGA1) and promotes the activation of the HMGA1/JNK/c-Jun axis in lung cancer to stimulate cancer cell growth and metastasis [102].